Similar articles for PMID: 17877917

Year	Number of Results
1999	1
2001	2
2002	1
2003	1
2004	7
2005	13
2006	18
2007	10
2008	4
2009	8
2010	5
2011	10
2012	10
2013	5
2014	6
2015	7
2016	10
2017	6
2018	5
2019	1
2020	5
2021	8
2022	8
2023	1
2024	0

1

The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis.

Virani SS, Nambi V. Virani SS, et al. Curr Atheroscler Rep. 2007 Aug;9(2):97-103. doi: 10.1007/s11883-007-0004-9. Curr Atheroscler Rep. 2007. PMID: 17877917 Review.

2

Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke.

Caslake MJ, Packard CJ. Caslake MJ, et al. Nat Clin Pract Cardiovasc Med. 2005 Oct;2(10):529-35. doi: 10.1038/ncpcardio0321. Nat Clin Pract Cardiovasc Med. 2005. PMID: 16186851 Review.

3

Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target.

Zalewski A, Macphee C. Zalewski A, et al. Arterioscler Thromb Vasc Biol. 2005 May;25(5):923-31. doi: 10.1161/01.ATV.0000160551.21962.a7. Epub 2005 Feb 24. Arterioscler Thromb Vasc Biol. 2005. PMID: 15731492 Review.

4

Clinical review: Lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent risk predictor for cardiovascular disease.

Sudhir K. Sudhir K. J Clin Endocrinol Metab. 2005 May;90(5):3100-5. doi: 10.1210/jc.2004-2027. Epub 2005 Feb 15. J Clin Endocrinol Metab. 2005. PMID: 15713711 Review.

5

[Lipoprotein-associated phospholipase A2: importance and perspectives].

Camici M. Camici M. Minerva Med. 2004 Apr;95(2):133-42. Minerva Med. 2004. PMID: 15272248 Review. Italian.

6

Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans.

Lavi S, McConnell JP, Rihal CS, Prasad A, Mathew V, Lerman LO, Lerman A. Lavi S, et al. Circulation. 2007 May 29;115(21):2715-21. doi: 10.1161/CIRCULATIONAHA.106.671420. Epub 2007 May 14. Circulation. 2007. PMID: 17502572

7

Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome.

Dohi T, Miyauchi K, Okazaki S, Yokoyama T, Ohkawa R, Nakamura K, Yanagisawa N, Tsuboi S, Ogita M, Yokoyama K, Kurata T, Yatomi Y, Daida H. Dohi T, et al. Atherosclerosis. 2011 Dec;219(2):907-12. doi: 10.1016/j.atherosclerosis.2011.09.019. Epub 2011 Sep 17. Atherosclerosis. 2011. PMID: 22024276 Clinical Trial.

8

Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses.

Shi Y, Zhang P, Zhang L, Osman H, Mohler ER 3rd, Macphee C, Zalewski A, Postle A, Wilensky RL. Shi Y, et al. Atherosclerosis. 2007 Mar;191(1):54-62. doi: 10.1016/j.atherosclerosis.2006.05.001. Epub 2006 Jun 9. Atherosclerosis. 2007. PMID: 16765356

9

Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A₂ activity in atherosclerotic plaque.

Otsuka F, Zhao X, Trout HH, Qiao Y, Wasserman BA, Nakano M, Macphee CH, Brandt M, Krug-Gourley S, Guo L, Ladich ER, Cheng Q, Davis HR, Finn AV, Virmani R, Kolodgie FD. Otsuka F, et al. Atherosclerosis. 2017 Dec;267:78-89. doi: 10.1016/j.atherosclerosis.2017.10.014. Epub 2017 Oct 14. Atherosclerosis. 2017. PMID: 29101839

10

Utility of Lp-PLA2 in lipid-lowering therapy.

Racherla S, Arora R. Racherla S, et al. Am J Ther. 2012 Mar;19(2):115-20. doi: 10.1097/MJT.0b013e3181e70d32. Am J Ther. 2012. PMID: 20634673 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

131 results

Results by year